New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
OverviewChart

Quote Panel

Shape
Updated June 22, 2025
1W 8.06 % 1M 10.20 % 3M 12.79 % 1Y -29.18 %

Key Metrics

Shape

  • Market Cap

    116.20M

  • Shares Outstanding

    34.69M

  • Share in Float

    29.37M

  • Dividende

    0

  • Earning Date

    12 Aug 2025

  • Price Target

    3.35

  • Average Volume

    248280

  • Beta

    1.641

  • Range

    1.84-5.31

  • Industry

    Biotechnology

  • Website

    https://www.achievelifesciences.com

  • Sector

    Healthcare

Fundamentals

Shape

Relative Strength

Shape

ACHV

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

Analyst rating

Last analyst upgrade/downgrade

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.23

arrow
arrow

N/A

-0.43
vs -1.08

Q3.23

arrow
arrow

N/A

-0.34
vs -1.35

Q4.23

arrow
arrow

N/A

-0.26
vs -0.83

Q1.24

arrow
arrow

N/A

-0.26
vs -0.50

Q2.24

arrow
arrow

N/A

-0.25
vs -0.43

Q3.24

arrow
arrow

N/A

-0.36
vs -0.34

Q4.24

arrow
arrow

N/A

-0.36
vs -0.26

Q1.25

arrow
arrow

N/A

-0.37
vs -0.26

Q2.25

arrow
arrow

N/A

-0.35
vs -0.25

Q3.25

arrow
arrow

N/A

-0.30
vs -0.36

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Q4.24

arrow
arrow

NA

NA  vs NA

Q1.25

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q2.23

arrow
arrow

-85%

-0.85
vs -20.30

Q3.23

arrow
arrow

-176%

-1.76
vs -0.85

Q4.23

arrow
arrow

+378%

3.78
vs -1.76

Q1.24

arrow
arrow

-13%

-0.13
vs 3.78

Q2.24

arrow
arrow

-20%

-0.20
vs -0.13

Q3.24

arrow
arrow

-40%

-0.40
vs -0.20

Q4.24

arrow
arrow

-59%

-0.59
vs -0.40

Q1.25

arrow
arrow

-125%

-1.25
vs -0.59

Institutionnal OwnershipShape

status-upQoQ

Q2.23

arrow
arrow

46

46
vs 39

18%

Q3.23

arrow
arrow

39

39
vs 46

-15%

Q4.23

arrow
arrow

33

33
vs 39

-15%

Q1.24

arrow
arrow

45

45
vs 33

36%

Q2.24

arrow
arrow

60

60
vs 45

33%

Q3.24

arrow
arrow

68

68
vs 60

13%

Q4.24

arrow
arrow

73

73
vs 68

7%

Q1.25

arrow
arrow

74

74
vs 73

1%

Earnings Growth

Latest News

ACHV

https://www.defenseworld.net

3 hours ago

Squarepoint Ops LLC Buys Shares of 17,519 Achieve Life Sciences, Inc. (NASDAQ:ACHV)
ACHV

globenewswire.com

7 hours ago

Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program
ACHV

globenewswire.com

8 hours ago

Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference
ACHV

globenewswire.com

8 hours ago

Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake
ACHV

seekingalpha.com

12 hours ago

Achieve Life Sciences, Inc. (ACHV) Q1 2025 Earnings Call Transcript
ACHV

seekingalpha.com

18 hours ago

Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk